In research models, this stack is being studied for its synergistic effects : Ipamorelin selectively stimulates growth hormone release, while CJC-1295 no DAC supports natural GH pulses without long-term receptor binding
CJC1295 and Ipamorelin are peptides known to stimulate growth hormone release, a key player in cell growth and metabolism
There are two distinct versions: CJC1295 with DAC Drug Affinity Complex extends the half-life to ~8 days, allowing weekly injections , but lacks pulsatility CJC1295 without DAC Shorter half-life (~30 minutes), ideal for physiological GH pulses , and preferred in performance enhancement settings For athletic performance and recovery, CJC1295 without DAC is most often chosen due to its compatibility with GHRP2 , MK677 , and BPC157
Clear, visible improvement usually takes 812 weeks
Stemmer K, Zani F, Habegger KM, Neff C, Kotzbeck P, Bauer M et al